113 results
8-K
EX-99.1
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
products continue to deliver impressive results with high patient satisfaction, with no adverse events. We are investing in sales improvement and long … -term opportunities with all of our products.
Q4 Financial Results
We recorded revenues of approximately $1.2 million for the quarter ended December 31
8-K
EX-10.7
NAOV
NanoVibronix Inc
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
, the Company currently sponsors and maintains the NanoVibronix, Inc. 2014 Long-Term Incentive Plan (the “Plan”);
WHEREAS, pursuant to the terms
8-K
EX-10.9
NAOV
NanoVibronix Inc
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
, the Company currently sponsors and maintains the NanoVibronix, Inc. 2014 Long-Term Incentive Plan (the “Plan”);
WHEREAS, pursuant to the terms
8-K
EX-10.1
d4hfovijcquqs0n
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.8
y48y 00dhotupu
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.4
v7f97 auqga
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.3
xlyb ydcq7xb
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.5
fj1cbt fwm3y
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.6
f2phbt zf655
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-10.2
ie0jg7
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
8-K
EX-99.1
ja7t53yw nqg9yflohv
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
EX-99.1
8usfj52
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am